Once-daily, single-tablet regimens have transformed care for persons living with human immunodeficiency virus type 1 (HIV-1); ...

Introduction Postoperative respiratory complications, particularly in patients with poor oral hygiene, contribute ...

Every crawl uncovers thousands of issues. Learn to separate urgent blockers from low-priority tasks with a repeatable ...

We're keeping tabs during the 2026/27 league year on how many players each NBA team is carrying on its roster.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data from its research pipeline for HIV treatment and prevention will be presented at the 26th ...

Introduction Stroke remains a leading cause of disability and mortality worldwide, with an urgent need for novel therapeutic strategies to improve recovery. Bupropion hydrochloride, a ...

If you ask a small child a simple maths question, such as 4+2, they may count on their fingers to work it out. Should we encourage young children to do this? This seemingly simple question is ...

Inconsistent reporting of age at cancer diagnosis limits the utility of non-interventional studies focused on adolescents and ...

Impact of venous thromboembolism on survival in multiple myeloma patients receiving bispecific antibody therapy: Insights from real-world data. Risk of second primary hematological malignancy post CAR ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Scientists have succeeded in making light behave like a "supersolid" ...

Depemokimab is an ultra-long-acting biologic therapy with enhanced binding affinity for interleukin-5 that may enable effective 6-month dosing intervals. In these phase 3A, randomized, ...